FEATURED/ARCHIVES (02/05/24)
×
Healthcare Resource Utilization and Costs among Patients with Schizophrenia Switching from Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis · April 2020
Articles
Current Therapeutic Research
×
Repetitive Transcranial Magnetic Stimulation for Psychiatric Symptoms in Long-Term Hospitalized Veterans with Schizophrenia: A Randomized Double-Blind Controlled Trial · September 2022
Articles
Frontiers in Psychiatry
×
Predictors of High-Intensity Psychiatric Service Utilization by Veterans Health Administration Patients with Early Psychosis · August 2021
Articles
Psychiatric Services
×
History of Suicide Attempt and Clozapine Treatment in Veterans with Schizophrenia or Schizoaffective Disorder · November 2022
Articles
Primary Care Companion for CNS Disorders
×
Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate among Veterans with Schizophrenia · October 2021
Articles
Neuropsychiatric Disease and Treatment
×
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression among Adults in the US Veterans Affairs Health Care System · September 2022
Articles
JAMA Psychiatry
×
Risk Factors and Antipsychotic Usage Patterns Associated with Terminal Delirium in a Veteran Long-Term Care Hospice Population · May 2021
Articles
NCBI>Federal Practitioner
×
VA/DoD Clinical Practice Guideline for Management of First-Episode Psychosis and Schizophrenia · January 2023
Publications (Guidelines)
US Department of Veterans Affairs
×
Preliminary Efficacy of CBT-I for Psychosis in a Veteran Sample (Meetings-Events) · May 2021
Abstracts
Sleep
×
Differences in Antipsychotic Treatment Discontinuation among Veterans with Schizophrenia in the U.S. Department of Veterans Affairs · July 2021
Articles
American Journal of Psychiatry